$0.6390
-0.14-18.18%
Last update: Nov 5, 5:19 PM
InspireMD Inc
NSPRNASDAQ
The average analyst price target for InspireMD is $4, 538.7% above the current price. Of 2 analysts, 2 rate it Buy. Targets range from $3 to $5. The latest change came on May 5, 2026, when Piper Sandler lowered its price target on InspireMD from $4 to $3 and kept an Overweight rating.
Price Target Range — 4 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
